MENU

SLDB Solid Biosciences Forecast, Technical & Fundamental Analysis

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases... Show more

Industry: #Biotechnology
SLDB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
SLDB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SLDB is expected to report earnings to rise 12.47% to -42 cents per share on March 16

Solid Biosciences SLDB Stock Earnings Reports
Q4'26
Est.
$-0.43
Q2'26
Beat
by $0.07
Q1'26
Beat
by $0.13
Q4'25
Beat
by $0.09
Q3'25
Beat
by $0.17
The last earnings report on August 06 showed earnings per share of -37 cents, beating the estimate of -44 cents. With 231.47K shares outstanding, the current market capitalization sits at 643.35M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JUNS2.280.23
+11.22%
Jupiter Neurosciences Inc
UE20.660.73
+3.66%
Urban Edge Properties
DOC19.480.45
+2.36%
Healthpeak Properties
NVRI17.98-0.44
-2.39%
Enviri Corporation
SAMG10.85-0.33
-2.95%
Silvercrest Asset Management Group

SLDB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with EDIT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-3.23%
EDIT - SLDB
63%
Loosely correlated
-3.75%
RCKT - SLDB
54%
Loosely correlated
+1.23%
BEAM - SLDB
54%
Loosely correlated
-4.99%
IMNM - SLDB
53%
Loosely correlated
+7.58%
TSHA - SLDB
53%
Loosely correlated
-3.15%
More
A.I. Advisor
published General Information

General Information

a developer of novel gene therapy platform for advancing disease

Industry Biotechnology

Industry
Biotechnology
Address
500 Rutherford Avenue
Phone
+1 617 337-4680
Employees
121
Web
https://www.solidbio.com
Solid Biosciences (SLDB) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com